[1] XU ZW, LI YS.Pathogenesis and treatment of parenteral-nutrition-associated liver disease[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(6): 586-596. [2] CHU YK, WU ML, WANG SZ, et al.Significance of parenteral nutrition support in patients with perioperative liver cirrhosis[J]. Infectious Diseases Information(传染病信息), 2014, 27(4): 249-252. [3] COHEN J, CHIN WD.Nutrition and sepsis[J]. World Rev Nutr Diet, 2013, 105: 116-125. [4] Drug induced liver disease group of hepatology branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of drug-induced liver injury[J]. Chinese Journal of Hepatology(中华肝脏病杂志), 2015, 23(11): 1752-1769. [5] WU GH.Theory and practice of clinical nutrition therapy[M]. Shanghai: Shanghai Science and Technology Press(临床营养治疗理论与实践), 2015: 156-159. [6] ZHONG B, LIU QW, LI Y, et al.Analysis of the effect of PIVAS pharmacist intervention on irrational parenteral nutrition orders[J]. Pharmacy Today(今日药学), 2018, 28(12): 848-850. [7] HE ZM, YANG L, PENG JZ.Rationality analysis and evaluation of total parenteral nutrition prescription in a hospital[J]. Modern Medicine and Health(现代医药卫生), 2018, 34(22): 3539-3541. [8] COBER MP, KILLU G, BRATTAIN A, et al.Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease[J]. J Pediatr, 2012, 160(3): 421-427. [9] WEI Y, WANG D, TOPCZEWSKI F, et al.Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells[J]. American Journal of Physiology-Endocrinology and Metabolism, 2006. 291(2): E275-E281. [10] NAMGALADZE D, LIPS S, LEIKER TJ, et al.Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses[J]. Diabetologia, 2014, 57(5): 1067-1077. [11] WANG D, WEI Y, PAGLIASSOTTI MJ.Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis[J]. Endocrinology, 2006, 147(2): 943-951. [12] ZHU L, REN JT, GUAN W, et al.Analysis of basic elements of case reports of drug-induced liver injury[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018,15(11): 663-667. [13] WEI L, ZHAO CJ.Pharmaceutical care of clinical pharmacists participating in the treatment of parenteral nutrition related liver damage[J]. Chinese Pharmacy(中国药房), 2017, 28(17): 2429-2432. [14] HULSHOFF A, SCHRICKER T, ELGENDY H, et al.Albumin synthesis in surgical patients[J]. Nutrition, 2013, 29(5): 703-707. [15] Guangdong Pharmaceutical Association.Parenteral nutrition clinical pharmacy consensus (Second Edition)[J]. Pharmacy Today(今日药学), 2017, 27(5): 289-303. [16] LI N, YU JC, CAI W.Clinical parenteral and enteral nutrition support therapeutics(临床肠外肠内营养支持治疗学)[M]. Beijing: China Medical Electronic Audio Visual Publishing House, 2012: 236-240. [17] LIU GY, SUN Y.Clinical pharmacy intravenous admixture technology[M]. Beijing: People's Military Medical Press(临床静脉用药集中调配技术), 2011: 129-130. |